Gå direkte til innhold
 

Approximately NOK 60 million available for Innovation Projects for the Industrial Sector

The Programme for Global Health and Vaccination Research (GLOBVAC) is announcing approximately NOK 60 million in funding over a 3-4 year period for Innovation Projects for the Industrial Sector. Norwegian companies are invited to apply.

Innovasjonsprosjekt i næringslivet Velg
Søknadsfrist:
13.02.2013 13:00 CET

Status:

Gjennomført

Antatt tilgjengelige midler:

Approximately NOK 60 million

Føringer og viktige forhold for alle søknadstyper i utlysningen:

Before filling out an application, please note that both general requirements for innovation projects for the industrial sector, as well as special requirements for this particular announcement, must be fulfilled. For general requirements, please see link

Eligibility
Projects within each of the Programme’s four thematic areas are eligible in low- and lower-middle income countries (LMICs), as defined in the OECD DAC list.

If other aspects of competing applications are considered equal, priority will currently be given to the African countries of Burundi, Ethiopia, Liberia, Madagascar, Malawi, Mali, Mozambique, Sudan, South Sudan, Tanzania, Uganda and Zambia; the Asian countries of Afghanistan, Nepal, Pakistan, Sri Lanka and East Timor; and Palestine.

However, projects directed at other low- and lower-middle income countries are also encouraged.

Important criteria
In order to be considered for funding, proposals submitted for this call must demonstrate a sufficiently high standard concerning the following criteria:

  • Level of innovation
  • R&D project level and quality
  • Implementation capacity

Priorities for this call
Importance will be attached to the following features of the proposals:

  • Potential for impact of the project in terms of value creation in Norway and societal benefits in low and lower-middle income countries. Proposals must comprise an extract of a thorough and credible business plan for how the proposed innovation will be introduced and sustained in the targeted markets (e.g. in a given LMIC or region of LMIC).
  • Relevance for the health-related United Nations Millennium Development Goals (MDGs), i.e. child and maternal health and communicable diseases, as well as other major global health endeavours, within all four thematic areas of the Programme.
  • Norwegian capacity building and national collaboration must be an integral part of all projects. National collaborations should take advantage of complementary competence.
  • Collaborations and partnerships with highly qualified international groups, including partnerships with research groups and institutions in LMICs.
  • Proposals must include considerations on ethics related to the research project and ethical implications of the implementation of the intended innovation.
  • In instances where R&D project quality and relevance to the call are deemed equal, proposals for projects with women in key positions will be prioritised.


Important considerations

  • Proposals that can demonstrate a potential for commercial development and value creation in LMICs are encouraged.
  • Proposals with potential for ground-breaking research are encouraged.
  • Multidisciplinary research approaches are encouraged, e.g. to strengthen the methodology in intervention studies.
  • Public-private partnerships are encouraged.
  • Proposals should include considerations on sustainability beyond the potential funding period from the Programme.
     

Kontaktpersoner